Clarivate (CLVT) Competitors $5.24 +0.11 (+2.14%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CLVT vs. RTO, ALLE, WPP, CART, ULS, MEDP, STN, GLOB, HQY, and BILIShould you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Rentokil Initial (RTO), Allegion (ALLE), WPP (WPP), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Globant (GLOB), HealthEquity (HQY), and Bilibili (BILI). These companies are all part of the "business services" industry. Clarivate vs. Rentokil Initial Allegion WPP Maplebear UL Solutions Medpace Stantec Globant HealthEquity Bilibili Rentokil Initial (NYSE:RTO) and Clarivate (NYSE:CLVT) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their community ranking, profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Which has more volatility & risk, RTO or CLVT? Rentokil Initial has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Clarivate has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500. Do analysts rate RTO or CLVT? Rentokil Initial currently has a consensus price target of $29.00, suggesting a potential upside of 11.65%. Clarivate has a consensus price target of $7.25, suggesting a potential upside of 38.23%. Given Clarivate's higher probable upside, analysts plainly believe Clarivate is more favorable than Rentokil Initial.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rentokil Initial 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.43Clarivate 2 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer RTO or CLVT? In the previous week, Clarivate had 7 more articles in the media than Rentokil Initial. MarketBeat recorded 10 mentions for Clarivate and 3 mentions for Rentokil Initial. Clarivate's average media sentiment score of 0.47 beat Rentokil Initial's score of 0.39 indicating that Clarivate is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rentokil Initial 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Clarivate 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings and valuation, RTO or CLVT? Rentokil Initial has higher revenue and earnings than Clarivate. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRentokil Initial$6.68B1.96$473.93MN/AN/AClarivate$2.63B1.42-$911.20M-$1.99-2.64 Do institutionals & insiders have more ownership in RTO or CLVT? 9.9% of Rentokil Initial shares are owned by institutional investors. Comparatively, 85.7% of Clarivate shares are owned by institutional investors. 22.8% of Clarivate shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is RTO or CLVT more profitable? Rentokil Initial has a net margin of 0.00% compared to Clarivate's net margin of -50.00%. Clarivate's return on equity of 9.69% beat Rentokil Initial's return on equity.Company Net Margins Return on Equity Return on Assets Rentokil InitialN/A N/A N/A Clarivate -50.00%9.69%3.97% Does the MarketBeat Community favor RTO or CLVT? Clarivate received 45 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 53.93% of users gave Clarivate an outperform vote while only 25.00% of users gave Rentokil Initial an outperform vote. CompanyUnderperformOutperformRentokil InitialOutperform Votes325.00% Underperform Votes975.00% ClarivateOutperform Votes4853.93% Underperform Votes4146.07% SummaryClarivate beats Rentokil Initial on 11 of the 17 factors compared between the two stocks. Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Get Clarivate News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLVT vs. The Competition Export to ExcelMetricClarivateData processing & preparation IndustryComputer SectorNYSE ExchangeMarket Cap$3.73B$4.42B$23.84B$20.15BDividend YieldN/A3.00%2.76%3.50%P/E Ratio-2.6434.79263.3344.29Price / Sales1.425.943,241.8917.72Price / Cash2.6731.3933.2521.28Price / Book0.686.116.984.71Net Income-$911.20M$42.17M$660.19M$985.54M7 Day Performance21.13%6.11%3.67%3.73%1 Month Performance-21.01%8.04%4.11%3.70%1 Year Performance-27.85%14.68%20.93%27.73% Clarivate Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVTClarivate2.7131 of 5 stars$5.25+2.1%$7.25+38.2%-27.9%$3.73B$2.63B-2.6412,000Insider TradeRTORentokil Initial1.0668 of 5 stars$25.62-0.3%$29.00+13.2%-8.3%$12.94B$6.68B0.0062,900ALLEAllegion4.3803 of 5 stars$141.54+1.5%$144.60+2.2%+35.1%$12.30B$3.65B21.7412,400Positive NewsWPPWPP0.5111 of 5 stars$51.48+0.1%N/A+18.7%$11.71B$18.46B0.00114,732CARTMaplebear4.0139 of 5 stars$43.21+3.9%$47.29+9.4%+72.5%$11.10B$3.04B29.003,380ULSUL Solutions2.3277 of 5 stars$53.12+0.6%$49.00-7.8%N/A$10.63B$2.68B0.0015,233MEDPMedpace4.7474 of 5 stars$341.87+4.8%$380.00+11.2%+22.0%$10.14B$2.07B29.945,900STNStantec2.9949 of 5 stars$86.03+2.3%N/A+23.5%$9.81B$4.80B39.1028,000GLOBGlobant4.0868 of 5 stars$222.37+3.1%$229.06+3.0%+7.7%$9.58B$2.35B58.0629,150Analyst ForecastHQYHealthEquity3.7219 of 5 stars$104.83+1.8%$107.23+2.3%+56.1%$9.15B$999.59M87.363,150Positive NewsBILIBilibili2.2792 of 5 stars$18.88-1.7%$19.69+4.3%+30.1%$7.82B$3.19B-20.528,801Gap Down Related Companies and Tools Related Companies RTO Alternatives ALLE Alternatives WPP Alternatives CART Alternatives ULS Alternatives MEDP Alternatives STN Alternatives GLOB Alternatives HQY Alternatives BILI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:CLVT) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarivate Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Clarivate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.